Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis
|
August 1, 1997
Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis
K Sawada, K Ohnishi, T Kosaka, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 21, 2000
N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test
K Aoyama, K Matsubara, K Okada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer
P Schöffski, B Thate, G Beutel, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
January 22, 2000
[Induction of long-term remission for the first onset of severe enterocolitis Crohn's disease treated by leukocytapheresis alone]
K Sawada, K Ohnishi, A Egashira, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis
|
August 1, 1997
Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis
K Sawada, K Ohnishi, T Kosaka, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 21, 2000
N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test
K Aoyama, K Matsubara, K Okada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer
P Schöffski, B Thate, G Beutel, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
January 22, 2000
[Induction of long-term remission for the first onset of severe enterocolitis Crohn's disease treated by leukocytapheresis alone]
K Sawada, K Ohnishi, A Egashira, et al.
Page
of 7